[Magnesium: current studies--critical evaluation--consequences]
1Abteilung für Kardiologie, Universitätskrankenhaus Eppendorf, Hamburg.
Insights
Intravenous magnesium effectively treats certain heart rhythm disorders. However, its use in acute myocardial infarction, heart failure, and hypertension is still debated and not standard practice.
Area of Science:
- Cardiology
- Clinical Pharmacology
- Electrophysiology
Context:
- Magnesium's role in cardiovascular health is increasingly recognized.
- Numerous studies have investigated magnesium's therapeutic potential in various cardiovascular conditions.
- Evidence supports its efficacy in specific arrhythmias but remains inconclusive for others.
Purpose:
- To review the therapeutic efficacy of magnesium in cardiovascular diseases.
- To differentiate established uses from controversial applications of magnesium therapy.
- To assess magnesium's current standing in treating arrhythmias, myocardial infarction, heart failure, and hypertension.
Summary:
- High-dose intravenous magnesium is established for treating supraventricular and ventricular arrhythmias, including Torsade de pointes-tachycardia.
- The efficacy of magnesium in acute myocardial infarction, congestive heart failure, and arterial hypertension is not definitively proven.
- Magnesium is not considered a standard therapy for acute myocardial infarction.
Impact:
- Clarifies the established and controversial applications of magnesium in cardiovascular medicine.
- Provides a basis for clinical decision-making regarding magnesium supplementation.
- Highlights areas requiring further controlled research to establish definitive therapeutic guidelines.
Abstract:
The therapeutic efficacy of magnesium has been studied during recent years in a number of cardiovascular diseases: supraventricular and ventricular arrhythmias (multifocal atrial tachycardia, Torsade de pointes-tachycardia, glycoside-associated arrhythmias, sustained ventricular tachycardia), acute myocardial infarction, heart failure and arterial hypertension. Although only a few of these arrhythmias were studied under controlled conditions, the therapeutic efficacy of intravenous magnesium given in a high dose in these arrhythmias seems to be established. By contrary, the efficacy of magnesium in acute myocardial infarction, congestive heart failure and arterial hypertension remains controversial up to now. Magnesium cannot be regarded as standard therapy for example for patients with acute myocardial infarction.
